ACAD
38.88
-0.68
-1.72%
AEMD
3.78
+0.03
+0.80%
APRI
3.068
-0.012
-0.3766%
ARNA
1.47
+0.05
+3.52%
ATEC
3.55
+0.28
+8.56%
CNAT
4.95
+0.13
+2.70%
CRXM
0.218
+0.004
+1.69777%
CYTX
1.71
-0.07
-3.93%
DXCM
78.5
+0.54
+0.69%
GNMK
11.25
+0.31
+2.83%
HALO
12.27
+0.23
+1.91%
ILMN
160
-1.01
-0.63%
INNV
0.158
+0.003
+1.6129%
INO
6.68
-0.22
-3.19%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
100.38
-2.46
-2.39%
LPTN
2.93
-0.08
-2.66%
MBVX
3.06
-0.01
-0.33%
MEIP
1.71
+0.02
+1.18%
MNOV
6.1
+0.1
+1.67%
MRTX
5.6
-0.1
-1.75%
MSTX
0.12
0.00
-2.52%
NBIX
42.72
-0.36
-0.84%
NUVA
74.76
+0.25
+0.34%
ONCS
1.39
-0.03
-2.11%
ONVO
2.97
0.00
0.00%
OREX
4.44
+0.46
+11.56%
OTIC
14.55
-0.4
-2.68%
QDEL
21.15
-0.26
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
1.1
+0.05
+4.76%
RMD
71.96
+0.34
+0.47%
SPHS
2.59
-0.04
-1.52%
SRNE
5.1
-0.1
-1.92%
TROV
2
0.00
0.00%
VICL
2.167
+0.017
+0.7814%
VOLC
18
0.00
0.00%
ZGNX
10.5
-0.1
-0.94%
ACAD
38.88
-0.68
-1.72%
AEMD
3.78
+0.03
+0.80%
APRI
3.068
-0.012
-0.3766%
ARNA
1.47
+0.05
+3.52%
ATEC
3.55
+0.28
+8.56%
CNAT
4.95
+0.13
+2.70%
CRXM
0.218
+0.004
+1.69777%
CYTX
1.71
-0.07
-3.93%
DXCM
78.5
+0.54
+0.69%
GNMK
11.25
+0.31
+2.83%
HALO
12.27
+0.23
+1.91%
ILMN
160
-1.01
-0.63%
INNV
0.158
+0.003
+1.6129%
INO
6.68
-0.22
-3.19%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
100.38
-2.46
-2.39%
LPTN
2.93
-0.08
-2.66%
MBVX
3.06
-0.01
-0.33%
MEIP
1.71
+0.02
+1.18%
MNOV
6.1
+0.1
+1.67%
MRTX
5.6
-0.1
-1.75%
MSTX
0.12
0.00
-2.52%
NBIX
42.72
-0.36
-0.84%
NUVA
74.76
+0.25
+0.34%
ONCS
1.39
-0.03
-2.11%
ONVO
2.97
0.00
0.00%
OREX
4.44
+0.46
+11.56%
OTIC
14.55
-0.4
-2.68%
QDEL
21.15
-0.26
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
1.1
+0.05
+4.76%
RMD
71.96
+0.34
+0.47%
SPHS
2.59
-0.04
-1.52%
SRNE
5.1
-0.1
-1.92%
TROV
2
0.00
0.00%
VICL
2.167
+0.017
+0.7814%
VOLC
18
0.00
0.00%
ZGNX
10.5
-0.1
-0.94%
Home » Archive by Category

Xconomy

With New Program, DARPA To Encourage Safety “Brakes” For Gene Editing

October 5, 2016 – 11:18 am

[Updated 10/6/16, 12:17 p.m. See below.] Drugs that use molecular scissors to snip out or replace defective genes. Altered mosquitoes meant to sabotage entire disease-carrying populations. Both are…

[[Click headline to continue reading.]]

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

October 5, 2016 – 8:33 am

San Diego-based Organovo (NASDAQ: ONVO) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver…

[[Click headline to continue reading.]]

Gates Grant Helps Sirenas Extend Hunt for Drugs From Sea Organisms

October 3, 2016 – 5:43 am

San Diego-based Sirenas, which has developed technology to rapidly isolate and synthesize potential drug compounds from marine organisms, said it has received a $775,000 grant from the Bill &…

[[Click headline to continue reading.]]

Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More

September 30, 2016 – 7:25 am

The presidential race captivated millions of TV viewers this week as the first debate took place in Hofstra. But biotech watchers had other races on their mind. Who will be first to market with a new…

[[Click headline to continue reading.]]

Ginkgo Builds Out Robot Labs as Microbe Design Business Grows: Photos

September 29, 2016 – 6:00 am

If Ginkgo Bioworks has its way, robots and software will someday handle most of the genetic engineering work currently performed by scientists sitting at lab benches. Ginkgo is contributing to that…

[[Click headline to continue reading.]]

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

September 27, 2016 – 4:59 am

[Note: The headline has been corrected to better describe the company’s type of funding. 9/27/16, 2:09 p.m.] Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial…

[[Click headline to continue reading.]]

Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More

September 23, 2016 – 3:30 am

Another biopharma executive went before Congress to explain drug price hikes. Unlike Martin Shkreli, Mylan CEO Heather Bresch actually answered questions. Taking heat over the EpiPen scandal, she…

[[Click headline to continue reading.]]

In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial

September 23, 2016 – 1:40 am

Biotech CEO Jonathan Lim co-founded Ignyta in 2011 to commercialize a new approach to diagnosing and treating rheumatoid arthritis, based on discoveries that showed how changes in methyl group…

[[Click headline to continue reading.]]

Announcing Xconomy’s Agtech and Food Channel

September 21, 2016 – 5:00 am

A core tenet of Xconomy—and the reason behind our broad coverage across information technology, life sciences, energy, and more—is that the most interesting and important innovations often…

[[Click headline to continue reading.]]

Workforce Trends, Economy, & More: Q&A With Alexandria’s Joel Marcus

September 19, 2016 – 5:25 am

Think “innovation” and you might picture some scrappy entrepreneurs toiling away in a kitchen or garage, hoping the landlord doesn’t notice what they’re up to. But the reality…

[[Click headline to continue reading.]]